Cogent Biosciences, Inc. (COGT)
37.02
-0.44
(-1.17%)
USD |
NASDAQ |
Mar 06, 15:54
Cogent Biosciences Cash from Investing (TTM) : -399.53M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Merck & Co., Inc. | -13.74B |
| Sarepta Therapeutics, Inc. | 69.64M |
| BridgeBio Pharma, Inc. | -22.34M |
| Olema Pharmaceuticals, Inc. | -108.00M |
| Revolution Medicines, Inc. | 118.06M |